How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Interventional procedure overview of endoluminal gastroplication for gastro-oesophageal reflux disease

    Closed for comments This consultation ended on at   Request commenting lead permission

    References

    1. Grössmann N, Wolf S, Wild C (2021). Endoscopic plication therapy in patients with gastroesophageal reflux disease (GERD). AIHTA Decision Support Document No. 127. Austrian Institute for Health Technology Assessment (AIHTA).

    2. McCarty TR, Itidare M, Njei B et al. (2018). Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis. Endoscopy 50(7): 708–25.

    3. Testoni PA, Testoni S, Distefano G et al. (2019). Transoral incisionless fundoplication with EsophyX for gastroesophageal reflux disease: Clinical efficacy is maintained up to 10 years. Endoscopy International Open 7(5): e647–54.

    4. Bell RCW, Freeman K, Heidrick R et al. (2021). Transoral incisionless fundoplication demonstrates durability at up to 9 years. Therapeutic Advances in Gastroenterology 14: 17562848211004827.

    5. Trad KS, Barnes WE, Prevou ER et al. (2018). The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective. Surgical Innovation 25(2): 149–57.

    6. Testoni SG, Cilona MB, Mazzoleni G et al. (2022). Transoral incisionless fundoplication with Medigus ultrasonic surgical endostapler (MUSE) for the treatment of gastro-oesophageal reflux disease: outcomes up to 3 years. Surgical Endoscopy 36(7): 5023-31.

    7. Kalapala R, Karyampudi A, Nabi Z et al. (2022). Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: Results from a randomised, sham-controlled trial. Gut 71(4): 686-94.

    8. Chimukangara M, Jalilvand AD, Melvin WS et al. (2019). Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study. Surgical Endoscopy 33(4): 1304–9.

    9. Edriss H, El-Bakush A, Nugent K. (2014). Oesophageal perforation and bilateral empyema following endoscopic EsophyX transoral incisionless fundoplication. Clinical endoscopy 47(6): 560-3.

    10. Titus JM, Mason DP, Raymond DP et al. (2013). Oesophagopulmonary fistula and left lung abscess after transoral incisionless fundoplication. The Annals of Thoracic Surgery 96(2): 689–91.

    11. Weusten BL, Barret M, Bredenoord AJ et al. (2020). Endoscopic management of gastrointestinal motility disorders - part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 52(7): 600–14.

    12. Yadlapati R, Vaezi MF, Vela MF et al. (2018). Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel. The American Journal of Gastroenterology 113(7): 980–6.

    13. Pearl J, Pauli E, Dunkin B et al. (2017). SAGES endoluminal treatments for GERD. Surgical Endoscopy 31(10): 3783–90.

    14. Muthusamy VR, Lightdale JR et al. (2015). The role of endoscopy in the management of GERD. Gastrointestinal Endoscopy 81(6): 1305–10.